Contracts › HT942524C0057
HT942524C0057: Dha Sbir Direct Phase Ii H2D-0243 Rapid Sample Processing Device to Support Battlefield Wound Infection Diagnostics
Awarded to Zymeron Corporation by Defense Health Agency.
$3.0Mobligated
$3.0Mpotential value
19 July 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | HT942524C0057 |
|---|---|
| Awardee | Zymeron Corporation |
| Awarding agency | Defense Health Agency |
| Awarding office | DEFENSE HEALTH AGENCY |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | NC |
| Offers received | 3 |
| Period of performance | 20 September 2024 to 19 July 2027 |
| Potential end | 19 July 2027 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record